Alp Akonur

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 193(Granted Patents)

Company Filing History:

Baxter International Inc.

Baxter Healthcare Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11285248 - Therapy prediction and optimization for renal failure blood therapy (2022-03-29),

2. 10363351 - Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis (2019-07-30),

3. 9629949 - Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis (2017-04-25),

4. 9348975 - Optimizing therapy outcomes for peritoneal dialysis (2016-05-24),

5. 9132219 - Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis (2015-09-15),

6. 8926551 - Peritoneal dialysis therapy with large dialysis solution volumes (2015-01-06),

7. 8868350 - Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis (2014-10-21),

8. 8845570 - Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis (2014-09-30),

9. 8521482 - Simulation of patient drain phase in peritoneal dialysis (2013-08-27),

10. 8449500 - Flow pulsatility dampening devices for closed-loop controlled infusion systems (2013-05-28),

11. 8180574 - Simplified peritoneal equilibration test for peritoneal dialysis (2012-05-15),

12. 7918350 - Separation apparatus and method (2011-04-05),

13. 7297272 - Separation apparatus and method (2007-11-20),

Title: Innovations by Alp Akonur in Renal Therapy

Introduction

Alp Akonur, an accomplished inventor based in Evanston, IL, has made significant strides in the field of medical innovations, holding a total of 13 patents. His work primarily focuses on advancing renal failure blood therapy, catering to the vital needs of patients undergoing treatment for renal issues.

Latest Patents

Among his latest patents, Alp Akonur developed a renal failure blood therapy system designed to optimize therapy predictions and operations. This innovation includes a renal failure blood therapy machine that monitors concentration levels of various solutes removed from a patient’s blood at multiple times. The system is equipped with a display device that allows users to select specific solutes, while a programmed device estimates patient parameters based on the collected data. It further determines acceptable treatment options that meet predetermined clearance goals for selected solutes, greatly enhancing the personalization and effectiveness of renal therapy treatments, particularly in at-home hemodialysis scenarios.

Career Highlights

Alp Akonur’s career has seen him contribute to prominent healthcare companies such as Baxter Healthcare and Baxter International Inc. His role within these organizations has positioned him at the forefront of research and development efforts aimed at improving renal therapy techniques.

Collaborations

Throughout his career, Alp has collaborated with esteemed professionals in the field, including Ying-Cheng Lo and John Kenneth Leypoldt. These collaborations have fostered innovative approaches to renal therapy, pooling together a wealth of expertise to advance patient care.

Conclusion

Alp Akonur exemplifies the spirit of innovation within the medical technology sector. His focus on optimizing renal failure blood therapy not only showcases his inventive capabilities but also highlights the potential for improved patient outcomes through advanced technology. As his work continues to evolve, the impact of his inventions is poised to benefit countless individuals facing renal challenges.

This text is generated by artificial intelligence and may not be accurate.